Company Profile
Cody Laboratories, Inc.
Company Overview
Cody Laboratories, Inc. (“Cody Labs”) in beautiful Cody, Wyoming, strives to improve lives by providing affordable high quality pharmaceuticals to its customers. A wholly owned subsidiary of Lannett Company, Inc., Cody Labs manufactures the highest quality generic bulk active pharmaceutical ingredients under cGMP conditions while providing the finest quality customer service available in the industry.
If you're looking for a career at an extraordinary company in an exciting and beautiful location, Cody Labs is the place for you!
Located in scenic Cody, Wyoming, 50 miles from the east entrance to Yellowstone National Park, the area offers an undisputed quality of life including great hiking, hunting, fishing, sightseeing and camping options. With just under 10,000 residents, Cody also boasts a world-class museum and nightly rodeos from Memorial Day to Labor Day.
From small beginnings in 2000, Cody Labs has grown to an employee population of 135 and over 84,000 square feet of manufacturing and support space. Long-range plans include development of an additional manufacturing site on 25 acres in Cody and adding another 45 employees over the next 10-15 years.
Cody Labs is a dynamic company known for its casual, team-oriented work environment. We embrace diverse cultures and provide opportunities for career growth to employees at all levels. Our excellent benefit package and competitive salaries enhance the great work environment at Cody Laboratories.
Company History
Cody Laboratories, Inc. (Cody Labs), a wholly owned subsidiary of Lannett Company, Inc., produces active pharmaceutical ingredients (API's) and finished dosage forms of pain relief medication.
Established as a generic pharmaceutical company in 2000, Lannett Company purchased the business in 2007. Lannett Company, Inc. manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Based in Philadelphia, Lannett has been in the generic pharmaceutical industry for more than 75 years.
The current Cody Labs facility is 84,000 square feet and Cody Labs has continued to grow to its present staff of 135.
Cody Labs holds one of only seven licenses in the United States to import raw opiate material for the purpose of manufacturing. This allows Cody Labs to manufacture active pharmaceutical ingredients directly from plant extracts and, therefore, be more cost competitive in the global market. This import license also allows Cody labs to provide the API's which Lannett requires to produce finished dosage forms.
Lannett has a portfolio consisting of numerous products across a wide range of therapeutic areas. The ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate ourselves into certain specialty markets and achieve economies in production are all critical for success in the generic pharmaceutical industry. Having the manufacturing expertise, low overhead expenses and efficient product development, manufacturing and marketing capabilities help us remain competitive in the general pharmaceutical market.
In August, 2015, Lannett received the distinction of being named the fastest growing company in the US by Forbes Magazine. Adding two new acquisitions; Silarx located in Carmel, NY and Kremers Urban situated in Seymour, IN, more than doubled the size of Lannett’s staff and manufacturing space.
Lannett dedicates strategic capital toward developing new products to continually introduce new generic products into the marketplace. The company has cultivated a strong and dependable customer relationship by maintaining adequate inventory levels and demonstrating a responsive order filling system.
The generic drug industry continues to grow with the aging population and the continuing rate of proprietary drug products coming off patent. In addition, the controlled substance drugs are protected from foreign competition as long as a source is available in the United States.
Construction is underway to expand Cody Lab's capacity for manufacturing APIs with commissioning of the new automated facility expected in 2019.
Notable Accomplishments / Recognition
Cody Laboratories holds one of seven licenses to import raw opiate materials for the purposes of manufacturing pharmaceuticals. We are experiencing unprecedented growth with an aggressive expansion project designed to significantly increase manufacturing space to accommodate new products currently being developed.
Benefits
In addition to competitive salary ranges and a benefits package comparable to any in the industry, employees are offered the option to purchase Lannett Company's publicly traded stock at a discount. Cody Labs provides Term Life and AD&D as well as both Short Term and Long Term Disability for each employee. Professional and management positions include relocation and temporary housing reimbursement up to 20% of the annual salary.